Wandile Mhlongo
Financial Analyst
Johannesburg
Summary
With over a decade of specialized experience in Financial Planning and Analysis (FP&A) within the pharmaceutical industry, I have a proven track record of guiding organizations toward financial success. My career includes roles such as Senior Finance Analyst, Consolidation Analyst, and Business Partner, where I've led financial planning, budgeting, and forecasting initiatives. I excel in OPEX monitoring, strategic business case development, and financial controls oversight. I've implemented projects like TM1 and contributed to new product launches. My hands-on experience with advanced financial systems such as SAP, HFM, and TM1 has improved operational efficiency and financial reporting accuracy. Currently pursuing the CIMA qualification at a managerial level, I am dedicated to continuous professional development and eager to support forward-thinking organizations.
Overview
12
12
years of professional experience
Work History
Financial Analyst
Aspen Pharma South Africa
2 2024 - Current
- Financial planning and analysis for the Eli Lilly Portfolio as well as the Aspen Hospital and Vaccines portfolio working with cross functional teams namely Sales, marketing , supply chain and market access
- Business partner with Specialty Care BU.
- Ensure at the contractual financial factors between Aspen and Eli lilly are implemented
- Monthly review of Sales, OPEX and PNL including gross margin, investigating and explain variances.
- Monthly journals entries arising from the Eli Lilly and Aspen agreement
- Preparation of the monthly governance committee deck with Eli Lilly (financial results)
- Submission of monthly KPIs reports to Eli lilly.
- Contribution to the S&OP (demand planning) meetings with Supply Chain and Marketing.
Senior Financial Analyst
Eli Lilly and Company
07.2022 - 01.2024
- Led the planning and forecasting function for the affiliate, overseeing both revenue and operating expenses (OPEX) from initiation to completion
- Coordinated with cross-functional teams, including Marketing, Sales, Supply Chain, Pricing, and Reimbursement, to collaboratively build accurate forecasts
- Analyzed monthly results to ensure proper accounting for both Sales and OPEX, presenting outcomes to the CFO and Executive Committee (Exco)
- Monitored OPEX with budget holders, offering support in critical thinking for effective budget management
- Served as a Business Partner to Sales and Marketing teams, contributing to the development of business cases and strategy implementation derived from customer plans, including product pricing
- Provided oversight of the Order-to-Cash cycle
- Conducted AR analysis of customer aging, adjusting Bad Debt Reserves accordingly.
Finance Business Partner
Sanofi
08.2020 - 06.2022
- Led and coordinated comprehensive budgets and forecasts for the GenMed business, overseeing the full Profit and Loss spectrum from Sales through to Bottom-Line Income (BOI)
- Prepared Budget presentations for Global reviews, diligently identifying risks and opportunities to ensure strategic alignment
- Regularly monitored and challenged Operating Expenses (OPEX) in collaboration with Business heads, fostering a proactive approach to financial management
- Conducted monthly analysis and review of Sales and Profit and Loss (P&L), including a detailed examination of gross margin and OPEX
- Provided business units with relevant and useful financial information, enabling key stakeholders to make informed strategic decisions
- Worked on business cases for new product launches and various other business scenarios, contributing to the development of sound strategic initiatives
- Took on the responsibility of training and developing trainees, imparting knowledge and skills essential for their professional growth.
Consolidation Analyst
Sanofi
11.2018 - 07.2020
- Monitored and facilitated the monthly and quarterly consolidation closing process for approximately 40 entities within my designated regions
- Reviewed and analyzed reporting packages received from affiliates, focusing on both balance sheet and income statement components
- Provided training and guidance to affiliates, particularly in handling specific transactions like business combinations, asset acquisitions, divestments, and legal restructuring
- Executed the booking of consolidation adjustment entries to ensure accurate and compliant financial reporting
- Contributed significantly to the development of quarterly Group financial presentations, enhancing the overall clarity and coherence of information presented to the Group.
Financial Controller
Sanofi
08.2015 - 10.2018
- Successfully led the implementation of TM1 under the guidance of the Country Controller, enhancing the efficiency of financial processes
- Delivered useful and relevant financial information to business units, including performance analysis of sales, gross margin, and OPEX
- Provided vital support to business units in OPEX management, ensuring vigilant monitoring and minimizing variances
- Ensured quality and timely monthly reporting, particularly in Sales reporting (MARCO), maintaining a high standard of accuracy and efficiency
- Acted as custodian of the budget, managing and coordinating the budget process with the business
- This included overseeing assumptions (pricing, gross to net, customer policies, etc.) in the forecasting tool TM1
- Collaborated with Business Unit heads in OPEX forecasting, analyzing trends and aligning with business needs
- Autonomously managed the Clinical Study Unit by providing day-to-day support, facilitating month-end reporting of OPEX and headcount, and effectively coordinating the budget and forecasting process.
Financial Controller Trainee
Sanofi
03.2014 - 07.2015
- Autonomous and successful management of the implementation of the New Finance Model, a corporate project critical to our financial operations
- Developed a comprehensive understanding of diverse Sanofi business activities, contributing to a holistic perspective on the organization's financial landscape
- Responsible for financial reporting of key performance indicators (KPIs) and indicators such as Days Sales Outstanding (DSO), Inventory Turnover (ITO), and Stock in Transit (SIT)
- Provided monthly performance analysis, encompassing Sales and Operating Expenses (OPEX), delivering insights crucial for informed decision-making
- Supported the Business Unit in OPEX management, actively monitoring and minimizing variances to enhance financial efficiency
- Effectively managed and coordinated budgeting and forecasting processes for the support functions, ensuring alignment with organizational goals and financial objectives.
Junior Accountant
Investec
01.2013 - 03.2014
Financial Accounting Intern
TotalEnergies
03.2012 - 12.2012
Education
Diploma in Management Accounting, Managerial Level - Management Accounting
CIMA
(In Progress)12.2026
Bachelor of Commerce (BCom) - Accounting
University of the Witwatersrand
National Senior Certificate - undefined
Ladysmith High School
Skills
Business Partner Support
Variance Analysis
Budgeting
Financial Statements
Accounting
Financial Accounting
Account Reconciliation
SAP
Microsoft Office
Finance
Timeline
Senior Financial Analyst
Eli Lilly and Company
07.2022 - 01.2024
Finance Business Partner
Sanofi
08.2020 - 06.2022
Consolidation Analyst
Sanofi
11.2018 - 07.2020
Financial Controller
Sanofi
08.2015 - 10.2018
Financial Controller Trainee
Sanofi
03.2014 - 07.2015
Junior Accountant
Investec
01.2013 - 03.2014
Financial Accounting Intern
TotalEnergies
03.2012 - 12.2012
Financial Analyst
Aspen Pharma South Africa
2 2024 - Current
Diploma in Management Accounting, Managerial Level - Management Accounting
CIMA
Bachelor of Commerce (BCom) - Accounting
University of the Witwatersrand
National Senior Certificate - undefined
Ladysmith High School
Similar Profiles
LAKSHMI SRIKANTH JANGALALAKSHMI SRIKANTH JANGALA
Sr.Scientist-I at ALPHAMED FORMULATIONS PRIVATE LIMITED (A wholly subsidiary of Aspen pharmacare, South Africa)Sr.Scientist-I at ALPHAMED FORMULATIONS PRIVATE LIMITED (A wholly subsidiary of Aspen pharmacare, South Africa)
MATTHEW EDWARDSMATTHEW EDWARDS
Store person at Aspen PharmaStore person at Aspen Pharma
DUDUZILE NDWANDWEDUDUZILE NDWANDWE
Deputy Director at Cochrane South Africa, South African Medical Research CouncilDeputy Director at Cochrane South Africa, South African Medical Research Council